Data Foundry

Drug recalls 2022

Doxycycline — Class II drug recall D-1182-2022

Terminated recall by Wedgewood Village Pharmacy, LLC, reported 2022-07-13, distributed nationwide. Lack of Processing Controls: Insanitary conditions observed during recent FDA Inspection

Recall numberD-1182-2022
Product typeDrug
ClassificationClass II
StatusTerminated
Voluntary or mandatedVoluntary
Recalling firmWedgewood Village Pharmacy, LLC, Swedesboro, NJ, United States
Recall initiated2022-06-10
Classified2022-07-07
Reported by FDA2022-07-13
Terminated2023-02-16
DistributedNationwide (US)
Quantity24 bottles
Lot numbers000-03641022, 000-03650269, 000-03693714, 000-03693748, 000-03706934, 000-03723022, 000-03766625, 000-03770510, 000-03780127, 000-03794760, 000-03799564, 000-03812001, 000-03840601, 000-03848586, 000-03850609, 000-03852462, 000-03852523, 000-03870004, 000-03872892, 000-03885204, 000-03892723, 000-03903599, 000-03904403
Expiration dates2022-06-17, 2022-06-28, 2022-07-10, 2022-08-06, 2022-09-01

Product

Doxycycline (as Calcium) (equivalent to 50mg/5mL), 10 mg/ml, 60 ml suspension bottles, Peppermint, Qty: 1, Wedgewood Village Pharmacy LLC, 405 Heron Dr, Ste 200, Swedesboro, NJ 08085

Reason for recall

Lack of Processing Controls: Insanitary conditions observed during recent FDA Inspection

Machine access

This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-1182-2022. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.

Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.